Publication | Open Access

Enhanced antitumor effects of DC-activated CIKs to chemotherapy treatment in a single cohort of advanced non-small-cell lung cancer patients

MedicineImmunologyPharmacologyImmune Checkpoint InhibitorEnhanced Antitumor EffectsBronchial NeoplasmSingle CohortDc-activated CiksLung CancerCancer TreatmentOncologyTumor Microenvironment